A prospectus concerning Biotie Therapies Corp.'s issue of shares to the company itself without consideration has been published


BIOTIE THERAPIES CORP.     STOCK EXCHANGE RELEASE     25 October 2010, at 3 p.m.




A prospectus concerning Biotie Therapies Corp.'s issue of shares to the company
itself without consideration has been published

The Finnish Financial Supervisory Authority has today, on 25 October 2010,
approved Biotie's prospectus concerning the share issue to the company itself
without consideration described in a stock exchange release earlier today. The
prospectus consists of two separate documents, a registration document and a
securities note, the latter containing also a summary.

The prospectus will be available at the headquarters of Biotie Therapies Corp.
at Tykistökatu 6, FI-20520 Turku, Finland as of 25 October 2010. The prospectus
will also be available on Biotie's homepage at www.biotie.com as of 25 October
2010. At this stage, the prospectus is available only in Finnish. An unofficial
English translation of the prospectus, which will not be approved by the Finnish
Financial Supervisory Authority, will be available at the company's homepage
when ready on or about 28 October 2010.

In Turku, 25 October 2010

Biotie Therapies Corp.
Timo Veromaa, President and CEO

For further information, please contact:
Virve Nurmi, Biotie Therapies Corp.
tel. +358 2 274 8900, e-mail: virve.nurmi@biotie.com

www.biotie.com

Distribution:
NASDAQ OMX Helsinki Ltd
Main Media





[HUG#1454959]